Company Profile For Myriad Genetics Inc

Myriad Genetics, Inc. is a healthcare company focused on the development and marketing of molecular diagnostic products. The Company is focused on providing physicians with information that guide the healthcare management of their patients to prevent disease, delay the onset of disease, or catch the disease at an earlier stage when it is treatable. As of June 30, 2009, the Company launched seven commercial molecular diagnostic products, including four predictive medicine and three personalized medicine products. It markets the products through its 300-person sales force in the United States. On June 30, 2009, the Company spun-off its research and drug development businesses for the treatment of cancers and other diseases into its wholly owned subsidiary, Myriad Pharmaceuticals, Inc. (MPI).

BRIEF: For the three months ended 30 September 2009, Myriad Genetics, Inc.'s revenues increased 22% to $85.1M. Net income from continuing operations increased 24% to $30.4M. Revenues reflect an increase in revenue from molecular diagnostics segment. Net income also reflects a decrease in other expenses, an increase in gross margin. The company is a healthcare company focused on the development & marketing of molecular diagnostic products.